Article info
PDFCystic fibrosis
Original research
Longitudinal assessment of lung clearance index to monitor disease progression in children and adults with cystic fibrosis
- Correspondence to Dr Alex R Horsley, Division of Infection, Immunity and Respiratory Medicine, The University of Manchester Faculty of Biology Medicine and Health, Manchester, UK; alexander.horsley{at}manchester.ac.uk
Citation
Longitudinal assessment of lung clearance index to monitor disease progression in children and adults with cystic fibrosis
Publication history
- Received January 20, 2021
- Accepted June 5, 2021
- First published July 22, 2021.
Online issue publication
March 15, 2022
Article Versions
- Previous version (22 July 2021).
- Previous version (27 October 2021).
- You are viewing the most recent version of this article.
Supplementary Data
This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.
Supplementary Data
This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY. Published by BMJ. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits others to copy, redistribute, remix, transform and build upon this work for any purpose, provided the original work is properly cited, a link to the licence is given, and indication of whether changes were made. See: https://creativecommons.org/licenses/by/4.0/.